News

Apyx Medical Corporation Announces Q3 2024 Financial Results

Apyx Medical Corporation Announces Q3 2024 Financial Results

Apyx Medical Corporation Prepares for Financial Results Release

Apyx Medical Corporation (NASDAQ: APYX) has announced the impending release of its third quarter fiscal year 2024 financial results. This announcement comes as the company continues to innovate within the medical technology sector. The results will be made publicly available before the market opens on November 8.

Details of the Financial Results Announcement

On the significant day of November 8, management will host a conference call at 8:00 a.m. Eastern Time. This conference call will allow stakeholders to gain insights into the financial performance of Apyx Medical for the quarter and will include a session for questions and answers. Interested participants can dial in to the call using 877-407-9039 or 201-689-8470 for international access and should reference access code 13749764. Specifically, participants should ask for the Apyx Medical Corporation Call to ensure they connect to the right session.

Accessing the Live Webcast

For those unable to join by phone, a live webcast of the conference call will be available. The webcast can be accessed via the company's official site in the Investor Relations section, providing an option to revisit the details in the future.

Apyx Medical’s Commitment to Innovation

Apyx Medical is known for its advanced energy technologies, particularly its proprietary helium plasma technology, marketed under the brand name Renuvion. This technology is transforming the landscape of both cosmetic surgery and hospital surgical markets. Renuvion, alongside J-Plasma, offers surgeons a unique tool for delivering controlled heat to tissues, allowing for precision in medical procedures.

Clinical Support and Product Effectiveness

The efficacy of Apyx Medical’s products is backed by a significant body of clinical research, with over 90 clinical documents supporting the use of Renuvion and J-Plasma. This clinical validation underscores the company’s dedication to enhancing surgical outcomes through innovative technology.

Investor Relations Contact Information

For any inquiries related to the financial announcement or company progress, Jeremy Feffer, Managing Director at LifeSci Advisors, can be reached at 212-915-2568. Jeremy remains a pivotal contact for investors looking to dive deeper into Apyx Medical’s financial health and strategic direction.

Overview of Apyx Medical Corporation

Apyx Medical Corporation stands at the forefront of advanced energy technology. Their mission is clear: to elevate the quality of life for individuals through innovative medical products. The company continues to make strides in both the cosmetic and surgical arenas, leveraging its deep expertise in unique waveforms through partnership agreements with other medical device manufacturers.

For more details regarding Apyx Medical and its innovative offerings, the company invites interested parties to explore their official website, which is regularly updated with the latest information.

Frequently Asked Questions

When will Apyx Medical report its third quarter financial results?

Apyx Medical will release its third quarter financial results on November 8, 2024, before the market opens.

How can I participate in the conference call?

To join the conference call, you can dial in at 877-407-9039 or 201-689-8470 for international calls. Use access code 13749764.

Will there be a webcast available for the conference call?

Yes, a live webcast will be available on the company’s website in the Investor Relations section for those who prefer to listen online.

What technologies does Apyx Medical focus on?

Apyx Medical specializes in advanced energy technologies, particularly in helium plasma technology, which is used in cosmetic and surgical procedures.

How can I contact Apyx Medical’s investor relations?

You can reach out to Jeremy Feffer, Managing Director at LifeSci Advisors, at 212-915-2568 for investor inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lupin Grabs FDA Nod: What Investors Should Know

Updated Category News Views 15

Lupin's Big Break Let's cut right to the chase: Lupin's latest FDA approval is no small potatoes. It's like getting a golden ticket in the pharma world, especially when you've been in the trenches as long as they have. As the first-to-file for their Amifampridine Tablets, 10 mg, this Indian giant is snagging that sweet 180-day exclusivity window. And in the cutthroat...

Continue Reading
ADC Therapeutics Preps Financial Results Release

Updated Category News Views 52

ADC Therapeutics: Eyes on the Financial Prize So here we are, folks—ADC Therapeutics is blitzing the stage and gearing up to spill the beans on their third-quarter saga come November 9, 2026. Who needs a crystal ball when you've got a press release to dissect every number and nuance? Anticipating the Numbers: What's at Stake? ADC Therapeutics has been riding the wave of...

Continue Reading
Northwood's $375M Boost: Satellite Network Expansion

Updated Category News Views 109

Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...

Continue Reading
JobPlanner Boosts Tools to Shield Margins in Construction

Updated Category News Views 80

Real-Time Solutions for Real-World Challenges JobPlanner is stepping up its game with some beefed-up financial management tools, and I gotta admit, it's like a lifeline in the raging sea of construction costs. We're talking about a souped-up Real-Time Job Costing Suite tailored for general and specialty contractors who are tired of watching their profits evaporate into...

Continue Reading
Atlas Power Expands with Boyland Electric Acquisition

Updated Category News Views 92

The Strategy Behind Atlas Power's Expansion Atlas Power Partners, no stranger to sizzling ambitions, has galvanized its portfolio by roping in Boyland Electric. This latest maneuver unfolds as Atlas hustles to become the go-to network for residential generator services. It’s a clear bet on 'quality over flair'—an ethos echoed by their CEO, David Fischer, who champions...

Continue Reading
First FedRAMP® 20x Class C Certification Earned

Updated Category News Views 36

Shifting Landscapes in Cybersecurity Certifications Change is the only constant in tech, and 360 Advanced sure knows how to ride that wave by leaping into the murky waters of FedRAMP's newest class. They’ve stamped their name on this historic FedRAMP® 20x Class C Certification by playing the role of the independent assessor for Perplexity's cloud service—a first...

Continue Reading
Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 53

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
Endeavor & GoPath's Game-Changing Cancer Test Launch

Updated Category News Views 88

Breaking Ground in Prostate Cancer Testing Just when you thought the medical field couldn't shake things up further, Endeavor Health and GoPath Diagnostics swoop in with a new genetic test for prostate cancer. This ain't just any run-of-the-mill test—it's the first of its kind to hit the clinical scene. The focus here is on sorting out which men with prostate cancer are...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 56

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 59

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Hat Acquires Neural Magic to Drive AI Innovations

Updated Category News Views 213

Red Hat Completes Acquisition of Neural Magic Red Hat, Inc., a leading provider of open source solutions, recently announced the completion of its acquisition of Neural Magic, a trailblazer in the performance of generative AI (gen AI) workloads. This strategic move enriches Red Hat's capacity to deliver optimized AI solutions tailored for diverse customer needs across the...

Continue Reading
Explore AgentFlux: Pioneering Privacy in Onchain Finance

Updated Category News Views 195

Introducing AgentFlux: A Breakthrough in Onchain Finance In the financial technology sphere, the need for security, privacy, and efficiency is paramount. That’s where AgentFlux steps in. This recently developed open-source framework by Axelar aims to revolutionize how institutions implement AI in their onchain financial practices. AgentFlux is designed to maintain...

Continue Reading
Signify's Share Buyback Program Details and Latest Updates

Updated Category News Views 205

Signify's Share Repurchase Program Overview Recently, Signify, recognized as a leader in the global lighting industry, provided an exciting update regarding its share repurchase program. In a span from May 5 to May 9, 2025, the company repurchased a total of 238,537 shares at an average cost of EUR 19.18 each. This endeavor amounted to an impressive EUR 4.6 million...

Continue Reading
Retail Growth at Modera Coral Springs—A Fresh Wave of Tenants

Updated Category News Views 202

A Look at Modera Coral Springs' Retail Innovations Well, would ya look at this? Mill Creek Residential is kicking up some dust down in Coral Springs, rolling out a lineup of new retailers at their Modera Coral Springs project. This whole mixed-use community thing—they're trying to create a real hub, ya know? Eight new tenants like Big Whiskey and Farmhouse Kitchen are...

Continue Reading
Parks Associates Strengthens Leadership Team to Drive Growth

Updated Category News Views 166

Parks Associates Strengthens Leadership Team for Future Growth Parks Associates has announced significant promotions within its leadership team aimed at enhancing the firm's direction and growth in its upcoming fortieth year. This strategic shift positions the company for further success in the dynamic market landscape. Promotions to Leadership Roles Jennifer Kent has...

Continue Reading